Related Experiment Video

Updated: Aug 14, 2026

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for

Jon I Scheinman1, Paul A Voziyan, John M Belmont

  • 1Department of Pediatrics, University of Kansas Medical Center, 3901 Rainbow Blvd, Room G-019 Miller Bldg, Kansas City, KS 66160-7330, USA. jscheinman@kumc.edu

Urological Research
|November 18, 2005
PubMed

Insights

Pyridoxamine (PM) effectively lowers urinary oxalate and glycolate levels in hyperoxaluric rats, reducing kidney stone formation. This shows promise for treating hyperoxaluria and preventing kidney stones.

Area of Science:

  • Nephrology
  • Biochemistry
  • Pharmacology

Background:

  • Hyperoxaluria leads to kidney stones (nephrolithiasis) and requires treatments reducing oxalate production.
  • Oxalate is synthesized from carbonyl intermediates like glycolaldehyde and glyoxylate.

Purpose of the Study:

  • To investigate pyridoxamine (PM) as a therapeutic agent to reduce oxalate production and excretion.
  • To evaluate the efficacy of PM in preventing calcium oxalate crystal formation in a rat model of hyperoxaluria.

Main Methods:

  • Administered PM to rats with induced hyperoxaluria.
  • Measured urinary oxalate and glycolate levels.
  • Assessed calcium oxalate crystal deposition in kidney tissues.

Main Results:

  • PM treatment significantly reduced endogenous urinary oxalate levels in rats.
  • In ethylene glycol-induced hyperoxaluria, PM lowered urinary glycolate and oxalate excretion by approximately 50%.
  • PM significantly decreased calcium oxalate crystal formation in the kidneys.

Conclusions:

  • Pyridoxamine effectively inhibits oxalate biosynthesis by reacting with key intermediates.
  • PM demonstrates therapeutic potential for primary hyperoxaluria and other kidney stone conditions.
  • Favorable toxicity profiles suggest PM is a promising candidate for human clinical use.

More Related Videos

Syntheses, Crystallization, and Spectroscopic Characterization of 3,5-Lutidine N-Oxide Dehydrate06:18

Syntheses, Crystallization, and Spectroscopic Characterization of 3,5-Lutidine N-Oxide Dehydrate

Published on: April 24, 2018

Related Concept Videos

Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Drug Elimination by Renal Route: Tubular Reabsorption01:22

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...